Welcome to the third Hepatocellular Carcinoma (HCC) Summit: From basic to clinical research: How to improve HCC clinical care? to be held in Geneva, Switzerland from 1-3 March 2018.
Brought to you by the European Association for the Study of the Liver (EASL).
HCC is considered one of the most important causes of death in patients affected with chronic liver disease. In the past years, major advances in the early diagnosis and treatment, particularly in advanced stages, have taken place.